Listed

Instil Bio, Inc.: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Aug 12, 2021 and accepted by EDGAR at Aug 12, 2021, 16:04 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-04-01 to 2021-06-30$0us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2021-01-01 to 2021-06-30$0us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2021-04-01 to 2021-06-30$21.2mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-01-01 to 2021-06-30$35.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-04-01 to 2021-06-30−$35.4mus-gaap:OperatingIncomeLoss
Operating income6 months2021-01-01 to 2021-06-30−$58.8mus-gaap:OperatingIncomeLoss
Income tax3 months2021-04-01 to 2021-06-30−$159.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2021-01-01 to 2021-06-30−$363.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-04-01 to 2021-06-30−$35.3mus-gaap:NetIncomeLoss
Net income6 months2021-01-01 to 2021-06-30−$58.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-04-01 to 2021-06-30−$0.27us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2021-01-01 to 2021-06-30−$0.71us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-04-01 to 2021-06-30−$0.27us-gaap:EarningsPerShareBasic
Basic EPS6 months2021-01-01 to 2021-06-30−$0.71us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-04-01 to 2021-06-30128,743,123 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2021-01-01 to 2021-06-3082,478,284 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2021-01-01 to 2021-06-30−$50.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2021-01-01 to 2021-06-30$17.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-06-30$566.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-06-30$574.5mus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$672.7mus-gaap:Assets
Current liabilitiesAt period end2021-06-30$23.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-06-30$37.2mus-gaap:Liabilities
Shareholders' equityAt period end2021-06-30$635.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001789769-21-000052. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.